Skip Navigation


Hum. Reprod. Advance Access originally published online on July 8, 2005
Human Reproduction 2005 20(10):2893-2898; doi:10.1093/humrep/dei159
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/10/2893    most recent
dei159v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jonard, S.
Right arrow Articles by Dewailly, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jonard, S.
Right arrow Articles by Dewailly, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Reproductive Endocrinology

Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries

Sophie Jonard1, Yann Robert2 and Didier Dewailly1,3

1 Department of Endocrine Gynaecology and Reproductive Medicine, and 2 Department of Radiology, Hôpital Jeanne de Flandre, CHRU, 59037 Lille, France

3 To whom correspondence should be addressed. E-mail: ddewailly{at}chru-lille.fr

BACKGROUND: This study revisited the ovarian volume (OV) as a diagnostic criterion for polycystic ovaries (PCO). Indeed, a threshold of 10 cm3 for the OV, chosen at the polycystic ovary syndrome (PCOS) international consensus held at Rotterdam in 2003, was to date not based on appropriate studies such as receiver operator characteristic (ROC) curve analysis. METHODS: This prospective study included 154 women with PCOS, selected by using the former National Institutes of Health criteria, who were compared with 57 women with normal ovarian function. Ultrasound examination was performed between cycle days 2 and 7 with a 7 MHz transvaginal transducer. RESULTS: Mean OV, ovarian area (OA) and follicle number (FN) values were significantly higher in the PCOS group than in controls. The area under the ROC curve (AUC) was >0.9 for all three criteria, indicating a satisfactory diagnostic potency for each. Concerning the OV, setting the threshold at 7 cm3 offered the best compromise between specificity (91.2%) and sensitivity (67.5%). In comparison, specificity and sensitivity were 98.2 and 45%, respectively, with a threshold at 10 cm3. Nevertheless, the highest AUC was obtained for FN (0.956) and then for OA (0.941). CONCLUSIONS: OV is a good diagnostic criterion for PCO but, on the basis of the present data, we propose to lower its threshold to 7 cm3. The FN >12 still appears as the best diagnostic criterion. The OA could be used as a surrogate for OV in difficult situations.

Key words: follicle number/ovarian area/ovarian volume/polycystic ovaries


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
R. Azziz
Diagnosing the diagnosis: why we must standardize the defining features of polycystic ovary syndrome
Ann Clin Biochem, January 1, 2008; 45(1): 3 - 5.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Catteau-Jonard, P. Pigny, A.-C. Reyss, C. Decanter, E. Poncelet, and D. Dewailly
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4138 - 4143.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. S. Legro
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
JAMA, February 7, 2007; 297(5): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Ibanez, A. Jaramillo, G. Enriquez, E. Miro, A. Lopez-Bermejo, D. Dunger, and F. de Zegher
Polycystic ovaries after precocious pubarche: relation to prenatal growth
Hum. Reprod., February 1, 2007; 22(2): 395 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H. F. Escobar-Morreale, W. Futterweit, O. E. Janssen, R. S. Legro, R. J. Norman, A. E. Taylor, et al.
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4237 - 4245.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Dewailly, S. Catteau-Jonard, A.-C. Reyss, M. Leroy, and P. Pigny
Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3922 - 3927.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Pigny, S. Jonard, Y. Robert, and D. Dewailly
Serum Anti-Mullerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 941 - 945.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Azziz
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 781 - 785.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.